【Taiyao】February 2026 Monthly Revenue NT$233 Million (YoY -20.5%)
Taiyao Chemical, a major manufacturer of active pharmaceutical ingredients (APIs), announced its February 2026 monthly revenue of NT$233 million, a 20.5% year-on-year decrease. This figure reflects changes in customer order patterns and product mix. The company has long focused on areas such as cholesterol reduction and Vitamin D.
📋 Article Processing Timeline
- 📰 Published: February 1, 2026 at 09:00
- 🔍 Collected: April 7, 2026 at 08:00 (1559h 0m after Published)
- 🤖 AI Analyzed: April 8, 2026 at 00:19 (16h 19m after Collected)
Company Code: 4746
Company Name: Taiyao
Industry: Biotechnology and Medical Industry
Data Month: 2026-02
Current Month Revenue: NT$232,724 thousand (NT$233 million)
Year-on-year change from same month last year: -20.5%
Company Name: Taiyao
Industry: Biotechnology and Medical Industry
Data Month: 2026-02
Current Month Revenue: NT$232,724 thousand (NT$233 million)
Year-on-year change from same month last year: -20.5%